Latest Insider Transactions at Iovance Biotherapeutics, Inc. (IOVA)
This section provides a real-time view of insider transactions for Iovance Biotherapeutics, Inc. (IOVA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IOVANCE BIOTHERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IOVANCE BIOTHERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,426
-0.94%
|
$8,852
$2.14 P/Share
|
|
Dec 02
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,417
+2.17%
|
-
|
|
Dec 02
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,786
-1.66%
|
$3,572
$2.14 P/Share
|
|
Dec 02
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,516
+3.17%
|
-
|
|
Dec 02
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,984
-1.75%
|
$3,968
$2.14 P/Share
|
|
Dec 02
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,906
+3.32%
|
-
|
|
Dec 01
2025
|
Raj K. Puri Chief Regulatory Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,467
-1.13%
|
$4,934
$2.23 P/Share
|
|
Dec 01
2025
|
Raj K. Puri Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,469
+2.44%
|
-
|
|
Dec 01
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
17,701
-3.72%
|
$35,402
$2.23 P/Share
|
|
Dec 01
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
41,669
+8.05%
|
-
|
|
Dec 01
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,464
-4.12%
|
$8,928
$2.23 P/Share
|
|
Dec 01
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,789
+7.49%
|
-
|
|
Dec 01
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,464
-3.91%
|
$8,928
$2.23 P/Share
|
|
Dec 01
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,789
+7.15%
|
-
|
|
Sep 02
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
22,127
-4.85%
|
$44,254
$2.19 P/Share
|
|
Sep 02
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
52,086
+10.24%
|
-
|
|
Sep 02
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,250
-5.9%
|
$12,500
$2.19 P/Share
|
|
Sep 02
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,306
+10.41%
|
-
|
|
Sep 02
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,448
-5.76%
|
$12,896
$2.19 P/Share
|
|
Sep 02
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,697
+10.19%
|
-
|
|
Sep 02
2025
|
Raj K. Puri Chief Regulatory Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,467
-1.15%
|
$4,934
$2.19 P/Share
|
|
Sep 02
2025
|
Raj K. Puri Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,470
+2.48%
|
-
|
|
Jun 05
2025
|
Daniel Gordon Kirby Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+50.0%
|
$30,000
$1.84 P/Share
|
|
Jun 02
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
22,127
-5.19%
|
$22,127
$1.76 P/Share
|
|
Jun 02
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
52,085
+10.88%
|
-
|
|
Jun 02
2025
|
Raj K. Puri Chief Regulatory Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,467
-1.16%
|
$2,467
$1.76 P/Share
|
|
Jun 02
2025
|
Raj K. Puri Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,469
+2.51%
|
-
|
|
Jun 02
2025
|
Jean Marc Bellemin Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,464
-6.87%
|
$4,464
$1.76 P/Share
|
|
Jun 02
2025
|
Jean Marc Bellemin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,789
+11.91%
|
-
|
|
Jun 02
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,250
-6.26%
|
$6,250
$1.76 P/Share
|
|
Jun 02
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,305
+10.97%
|
-
|
|
Jun 02
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,448
-6.11%
|
$6,448
$1.76 P/Share
|
|
Jun 02
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,695
+10.73%
|
-
|
|
May 23
2025
|
Raj K. Puri Chief Regulatory Officer |
BUY
Open market or private purchase
|
Direct |
5,600
+2.64%
|
$5,600
$1.74 P/Share
|
|
May 14
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Open market or private purchase
|
Direct |
25,000
+6.26%
|
$25,000
$1.69 P/Share
|
|
Mar 14
2025
|
Raj K. Puri Chief Regulatory Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,509
-1.23%
|
$7,527
$3.59 P/Share
|
|
Mar 14
2025
|
Raj K. Puri Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+3.93%
|
-
|
|
Mar 03
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,470
-26.48%
|
$133,880
$4.04 P/Share
|
|
Mar 03
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,497
+33.09%
|
-
|
|
Mar 03
2025
|
Raj K. Puri Chief Regulatory Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,984
-9.28%
|
$79,936
$4.04 P/Share
|
|
Mar 03
2025
|
Raj K. Puri Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,999
+21.79%
|
-
|
|
Mar 03
2025
|
Frederick G Vogt Interim CEO & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
95,413
-21.44%
|
$381,652
$4.04 P/Share
|
|
Mar 03
2025
|
Frederick G Vogt Interim CEO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
223,943
+33.47%
|
-
|
|
Mar 03
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,302
-27.55%
|
$133,208
$4.04 P/Share
|
|
Mar 03
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,106
+33.94%
|
-
|
|
Mar 03
2025
|
Jean Marc Bellemin Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
31,734
-36.09%
|
$126,936
$4.04 P/Share
|
|
Mar 03
2025
|
Jean Marc Bellemin Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,590
+39.99%
|
-
|
|
Jan 14
2025
|
Igor Bilinsky Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,578
-2.61%
|
$7,890
$5.89 P/Share
|
|
Jan 14
2025
|
Igor Bilinsky Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+4.45%
|
-
|
|
Jan 14
2025
|
Finckenstein Friedrich Graf Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,578
-2.41%
|
$7,890
$5.89 P/Share
|